(Q33684237)

28 July 2017

1 reference

title

What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections? (English)

1 reference

28 July 2017

Momméja-Marin H

1

1 reference

28 July 2017

Carbon C

series ordinal

2

1 reference

28 July 2017

publication date

1 June 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

57

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

851-853

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199957060-00002

28 July 2017

exact match

0 references

cites work

Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro

1 reference

12 December 2020

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis

1 reference

12 December 2020

How do we achieve cost-effective options in lower respiratory tract infection therapy?

1 reference

12 December 2020

Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens

1 reference

12 December 2020

Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society

1 reference

12 December 2020

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

12 December 2020

High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.

1 reference

12 December 2020

Temafloxacin syndrome: review of 95 cases

1 reference

12 December 2020

10.2165/00003495-199957060-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1034094156

0 references

Fatcat ID

release_klfdinhiufhtthsw34wha4y26q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/klfdinhiufhtthsw34wha4y26q

24 November 2022

mapped directly with Wikidata item

1 reference